| WST |
Report |
2Q26 net sales |
IN-LINE |
pred ~$839M vs. cons $846M |
MEDIUM |
| WST |
Report |
2Q26 adjusted diluted EPS |
MISS |
pred ~$2.08 vs. cons $2.11 |
MEDIUM |
| WST |
Report |
2Q26 HVP Components organic growth |
MISS |
pred ~15% vs. cons 17% |
LOW |
| WST |
Guide |
FY26 net-sales guidance |
LOWER |
guide ~$3.28B vs. cons $3.34B (FY26) |
MEDIUM |
| WST |
Guide |
FY26 adjusted diluted EPS guidance |
LOWER |
guide ~$8.35 vs. cons $8.62 (FY26) |
MEDIUM |
| WST |
Return |
Day-1 residual (stock − beta × S&P 500) |
-9.0% |
— |
MEDIUM |
| WST |
Return |
5-day cumulative residual |
-12.0% (FOLLOW-THROUGH) |
A modest 2Q revenue/EPS shortfall combined with a FY26 guide reset (~$3.28B sales and ~$8.35 EPS versus consensus of $3.34B and $8.62) would force out-period estimate cuts; cyber-related lost production, recovery costs, and lower implied 2H earnings outweigh an otherwise resilient HVP demand narrative. |
MEDIUM |